Aminoalkoxy-substituted coumarins: Synthesis and evaluation for reactivation of inhibited human acetylcholinesterase. 2022

Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
Food Chemistry, Central Institute of the Bundeswehr Medical Service Munich, Garching, Germany.

Reactivation of inhibited acetylcholinesterase remains an important therapeutic strategy for the treatment of poisoning by organophosphorus compounds, such as nerve agents or pesticides. Although drugs like obidoxime or pralidoxime have been used with considerable success, there is a need for new substances capable of reactivating acetylcholinesterase with a broader scope and increased efficacy. Possible screening candidates must fulfill two fundamental requirements: They must (i) show an affinity to acetylcholinesterase well balanced between sufficient binding and competitive inhibition and (ii) facilitate the nucleophilic cleavage of the phosphorylated catalytic serine residue. We attached a variety of nonaromatic primary and secondary amines to a coumarin core through selected alkoxy side linkers attached at coumarin positions 6 or 7 to obtain a small set of possible reactivators. Evaluation of their inhibition and reactivation potential in vitro showed some activity with respect to acetylcholinesterase inhibited by cyclosarin.

UI MeSH Term Description Entries
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D002801 Cholinesterase Reactivators Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. Insecticides, Organophosphate, Antagonists,Insecticides, Organothiophosphate, Antagonists,Organophosphate Insecticide Antagonists,Organothiophosphate Insecticide Antagonists,Antagonists, Organophosphate Insecticide,Antagonists, Organothiophosphate Insecticide,Insecticide Antagonists, Organophosphate,Insecticide Antagonists, Organothiophosphate,Reactivators, Cholinesterase
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
June 2013, European journal of medicinal chemistry,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
March 1972, Biochemistry,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
August 2020, Chemico-biological interactions,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
April 2004, Archives of toxicology,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
February 1955, Archives of biochemistry and biophysics,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
March 2016, Toxicology letters,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
January 2014, Combinatorial chemistry & high throughput screening,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
December 2009, The journal of physical chemistry. B,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
December 2005, European journal of medicinal chemistry,
Paul W Elsinghorst, and Timo Wille, and Danijela Barić, and Matthias D Mertens, and Madlen Baumann, and Jim Küppers, and Michael Gütschow
July 1981, Biochimica et biophysica acta,
Copied contents to your clipboard!